Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €864.50 | €900.00 | 4.106% |
| AbbVie Inc. | 43 | 0 | 21 | 0 | €155.50 | €176.30 | 13.377% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €975.80 | €1,049.8 | 7.580% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.44 | €75.00 | 20.115% |
| Sarepta Therapeutics | 13 | 0 | 12 | 0 | €136.95 | €180.00 | 31.435% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €449.00 | €459.80 | 2.405% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €289.30 | €305.58 | 5.626% |
| Pfizer Inc. | 37 | 4 | 10 | 0 | €25.65 | €40.00 | 55.976% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.50 | €291.35 | 38.406% |
| Merck & Co. Inc. | 35 | 1 | 6 | 0 | €116.00 | €125.02 | 7.773% |
| Exact Sciences | 20 | 0 | 6 | 0 | €40.74 | €74.22 | 82.189% |
| Abbott Laboratories | 21 | 0 | 3 | 0 | €94.07 | €115.05 | 22.303% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €161.72 | €198.11 | 22.503% |